
GE HealthCare
GEHC · NASDAQ · Health Care
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $37,5 bn
- Div. yield
- 0,2%
- Year to date
- +1,2%
Ratio score
Not enough data for a score
The score is calculated when at least 6 of 10 metrics are known.
Key metrics
2 ✓ · 0 — · 0 ✕ · 8 n/a
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 17,4 | 17,9 | 25,1 |
| Forward P/E | 14,2 | — | 16,2 |
| PEG | 1,7 | — | 2,2 |
| P/S | 1,7 | 1,8 | 2,2 |
| EV/EBITDA | 14,0 | 14,1 | 17,3 |
| P/FCF | 19,9 | — | 19,5 |
| P/B | 3,2 | 4,1 | 3,4 |
Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 29 analysts
- Buy
- 21
- Hold
- 8
- Sell
- 0
Beat the EPS forecast in 3 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | 1,23 | 1,34 | Up +9,1% |
| Q2 2026 | 1,06 | 1,13 | Up +7,0% |
| Q1 2026 | 1,07 | 0,99 | Down −7,5% |
| Q4 2025 | 1,43 | 1,44 | Up +1,0% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: purchases $6,42 m (8 people), no sales.
| Name | Amount | Shares | Price |
|---|---|---|---|
| lobo kevin22 May 2026 · open-market purchase | $641 800 | 10 000 | $64,18 |
| hochman rodney f12 May 2026 · open-market purchase | $100 365 | 1 618 | $62,03 |
| yang watkin phoebe l.8 May 2026 · open-market purchase | $63 006 | 1 000 | $63,01 |
| stromberg william j6 May 2026 · open-market purchase | $61 689 | 1 000 | $61,69 |
| culp h lawrence jr6 May 2026 · open-market purchase | $5,00 m | 80 805 | $61,88 |
| saccaro james1 May 2026 · open-market purchase | $200 585 | 3 310 | $60,60 |
| jimenez frank r30 Apr 2026 · open-market purchase | $105 788 | 1 750 | $60,45 |
| arduini peter j30 Apr 2026 · open-market purchase | $249 827 | 4 169 | $59,93 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Health Care
- Exchange
- NASDAQ
- Country
- US
- IPO date
- 15 Dec 2022
- Website
- www.gehealthcare.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
CNCCentene Corporation | $74,77 | 72★★★★★★★★★would consider | 24,2 | +9,7% | 0,7% |
RMDResMed | $238,19 | 83★★★★★★★★★would consider | 21,3 | +9,0% | 27,8% |
DXCMDexcom | $81,61 | 89★★★★★★★★★★would consider | 31,4 | +13,0% | 19,4% |
LHLabcorp | $372,46 | 56★★★★★★★★would watch | 30,0 | +6,0% | 6,9% |
DGXQuest Diagnostics | $262,21 | 61★★★★★★★★would watch | 25,5 | +9,1% | 9,5% |
Ratio — a score by our methodology, not an investment recommendation.




